Consider drugs:5 If BMI ≥27 w/ ≥1 obesity-associated comorbidity, motivated to ↓ wt [E], individualize risk/benefit of optional FDA-approved obesity-drug adjunct to comprehensive lifestyle intervention

By rray, 11 December, 2014
Exclude Patient Type Detail Header
No
Detail Type
Text
Patient Type Detail Header (Long)
Consider drugs:<sup>5</sup> If BMI ≥27 w/ ≥1 obesity-associated comorbidity, motivated to ↓ wt [E], individualize risk/benefit of optional FDA-approved obesity-drug adjunct to comprehensive lifestyle intervention